• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真实环境下慢性阻塞性肺疾病预后和特征的更新:一项多机构注册研究的 5 年随访分析。

Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.

机构信息

Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Department of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.

出版信息

BMC Pulm Med. 2024 Nov 6;24(1):556. doi: 10.1186/s12890-024-03347-5.

DOI:10.1186/s12890-024-03347-5
PMID:39506773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11539611/
Abstract

BACKGROUND

We conducted a prospective observational study to elucidate the long-term prognosis and management of chronic obstructive pulmonary disease (COPD) in clinical practice in Japan in the mid-2010s.

METHODS

This prospective cohort study included 29 facilities. Data from 427 patients clinically diagnosed with COPD, enrolled between September 2013 and April 2016, were analyzed. Interstitial pneumonia was excluded through a central multidisciplinary discussion. Follow-up data were collected for up to 5 years after patient registration.

RESULTS

At the time of registration, 53 patients clinically diagnosed with COPD did not have airflow limitation (AFL). In the cohort with AFL (n = 374), 232 patients completed a 5-year follow-up, while 49 patients died during the 1576.6 person-years of observation. The mean age was 71.7 years with an overall 5-year survival rate of 85.4%. Stratified by % forced expiratory volume in one second (FEV1), survival rates were 93.6% in the mild and moderate AFL group, 82.5% in the severe AFL group, and 66.1% in the very severe AFL group. The prognosis of the subpopulation without AFL was poor with a 5-year survival of 81.6%. This subpopulation exhibited respiratory symptoms, low vital capacity and total lung capacity, and emphysematous changes.

CONCLUSIONS

Our study presents the 5-year survival and real-world clinical practice scenario of a prospective cohort of patients clinically diagnosed with COPD in Japan in the mid-2010s. The survival rates of our cohort were numerically better than the Japanese cohort in the 1990s, regardless of the high median age of this cohort. Overall, 12.4% of the patients in this cohort with no AFL at registration exhibited respiratory symptoms and distinct spirometric patterns, and had a poor prognosis.

摘要

背景

我们进行了一项前瞻性观察研究,旨在阐明 2010 年代中期日本临床实践中慢性阻塞性肺疾病(COPD)的长期预后和管理。

方法

这项前瞻性队列研究包括 29 家机构。分析了 2013 年 9 月至 2016 年 4 月期间临床诊断为 COPD 的 427 例患者的数据。通过中央多学科讨论排除间质性肺炎。在患者登记后,最多可收集 5 年的随访数据。

结果

在登记时,53 例临床诊断为 COPD 的患者没有气流受限(AFL)。在有 AFL 的队列中(n=374),232 例患者完成了 5 年随访,而在 1576.6 人年的观察期间有 49 例患者死亡。平均年龄为 71.7 岁,总体 5 年生存率为 85.4%。按第 1 秒用力呼气量(FEV1)%分层,轻度和中度 AFL 组的生存率为 93.6%,重度 AFL 组为 82.5%,非常重度 AFL 组为 66.1%。无 AFL 的亚组预后较差,5 年生存率为 81.6%。该亚组存在呼吸症状、肺活量和总肺容量低以及气肿性改变。

结论

我们的研究提供了 2010 年代中期日本临床诊断为 COPD 的前瞻性队列患者的 5 年生存率和真实世界临床实践情况。无论该队列的中位年龄较高,其生存率在数值上均优于 20 世纪 90 年代的日本队列。总的来说,登记时无 AFL 的患者中有 12.4%存在呼吸症状和明显的肺功能模式,预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84be/11539611/06cf3aea2ca6/12890_2024_3347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84be/11539611/e3b21d3f9d5f/12890_2024_3347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84be/11539611/06cf3aea2ca6/12890_2024_3347_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84be/11539611/e3b21d3f9d5f/12890_2024_3347_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84be/11539611/06cf3aea2ca6/12890_2024_3347_Fig2_HTML.jpg

相似文献

1
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.真实环境下慢性阻塞性肺疾病预后和特征的更新:一项多机构注册研究的 5 年随访分析。
BMC Pulm Med. 2024 Nov 6;24(1):556. doi: 10.1186/s12890-024-03347-5.
2
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.真实环境中哮喘和/或慢性阻塞性肺疾病患者的症状与肺功能的关系:NOVEL 观察性纵向研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254212. doi: 10.1177/17534666241254212.
3
Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.未识别气流受限患者 COPD 的诊断和临床病程。
Int J Chron Obstruct Pulmon Dis. 2013;8:199-208. doi: 10.2147/COPD.S39555. Epub 2013 Apr 18.
4
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.伴有轻度气流受限的慢性阻塞性肺疾病:当前认知与未来研究建议——六家科学学会的共识文件
Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017.
5
Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.在商业保险人群中,根据疾病严重程度分层的 COPD 患者的医疗资源利用和恶化率。
J Manag Care Spec Pharm. 2019 Feb;25(2):205-217. doi: 10.18553/jmcp.2019.25.2.205.
6
Lung function decline and incidence of chronic obstructive pulmonary disease in participants with spirometry-defined small airway dysfunction: a 15-year prospective cohort study in China.肺活量测定定义的小气道功能障碍参与者的肺功能下降及慢性阻塞性肺疾病发病率:一项在中国进行的15年前瞻性队列研究
Respir Res. 2025 Apr 28;26(1):169. doi: 10.1186/s12931-025-03244-3.
7
Prevalence of airflow limitation on medical check-up in Japanese subjects.日本受试者体检中气流受限的患病率。
J UOEH. 2007 Sep 1;29(3):209-19. doi: 10.7888/juoeh.29.209.
8
Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry.根据2017年慢性阻塞性肺疾病全球倡议(GOLD)分类的日本慢性阻塞性肺疾病患者的临床特征及预后:石卷慢性阻塞性肺疾病网络登记研究
Int J Chron Obstruct Pulmon Dis. 2018 Dec 6;13:3947-3955. doi: 10.2147/COPD.S182905. eCollection 2018.
9
Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.哮喘伪装成慢性阻塞性肺疾病:一项符合 GOLD 慢性阻塞性肺疾病定义的吸烟者研究。
Respiration. 2011;82(1):19-27. doi: 10.1159/000323075. Epub 2011 Jan 29.
10
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.非吸烟慢性阻塞性肺疾病患者与吸烟慢性阻塞性肺疾病患者的临床特征比较:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.

引用本文的文献

1
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort study.慢性阻塞性肺疾病(COPD)根据GOLD和STAR严重程度分期的死亡率及急性加重风险:一项为期5年的多中心前瞻性队列研究
Sci Rep. 2025 May 30;15(1):19097. doi: 10.1038/s41598-025-05033-w.
2
Blood urea nitrogen to serum albumin ratio as a prognostic marker for 28-day mortality in atrial fibrillation: a retrospective cohort study.血尿素氮与血清白蛋白比值作为心房颤动患者28天死亡率的预后标志物:一项回顾性队列研究。
Front Cardiovasc Med. 2025 May 9;12:1533575. doi: 10.3389/fcvm.2025.1533575. eCollection 2025.

本文引用的文献

1
Preserved Ratio Impaired Spirometry (PRISm): A Global Epidemiological Overview, Radiographic Characteristics, Comorbid Associations, and Differentiation from Chronic Obstructive Pulmonary Disease.保留比预计值差的肺量测定(PRISm):全球流行病学概述、影像学特征、合并症关联,以及与慢性阻塞性肺疾病的鉴别。
Int J Chron Obstruct Pulmon Dis. 2024 Mar 15;19:753-764. doi: 10.2147/COPD.S453086. eCollection 2024.
2
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.特发性肺纤维化(IPF)或非特发性间质性肺炎患者的生存和急性加重:前瞻性多机构患者登记的 5 年随访分析。
BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2023-001864.
3
Undiagnosed and 'overdiagnosed' COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis.在基层医疗环境中使用支气管扩张剂后肺量测定法诊断和“过度诊断” COPD:系统评价和荟萃分析。
BMJ Open Respir Res. 2023 Apr;10(1). doi: 10.1136/bmjresp-2022-001478.
4
Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies.20 世纪 90 年代至 21 世纪初慢性阻塞性肺疾病患者死亡率的变化:两项前瞻性队列研究的汇总分析。
BMJ Open. 2023 Mar 7;13(3):e065896. doi: 10.1136/bmjopen-2022-065896.
5
Risks of Mortality and Airflow Limitation in Japanese Individuals with Preserved Ratio Impaired Spirometry.肺活量比值降低的日本个体的死亡风险和气流受限情况
Am J Respir Crit Care Med. 2022 Sep 1;206(5):563-572. doi: 10.1164/rccm.202110-2302OC.
6
Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.曾吸烟者中显著的肺量计过渡和保留的比值受损肺量计。
Chest. 2022 Mar;161(3):651-661. doi: 10.1016/j.chest.2021.09.021. Epub 2021 Sep 27.
7
Unique Mortality Profile in Japanese Patients with COPD: An Analysis from the Hokkaido COPD Cohort Study.日本 COPD 患者的独特死亡率特征:北海道 COPD 队列研究分析。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 4;15:2081-2090. doi: 10.2147/COPD.S264437. eCollection 2020.
8
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.中重度至极重度 COPD 患者两种糖皮质激素剂量三联吸入治疗。
N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24.
9
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.氟替卡松维兰特罗/乌美溴铵粉雾剂降低慢性阻塞性肺疾病患者全因死亡率。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1508-1516. doi: 10.1164/rccm.201911-2207OC.
10
Characteristics of tobacco-related lung diseases in Fukuoka Prefecture, Japan: A prospective, multi-institutional, observational study.日本福冈县烟草相关肺部疾病的特征:一项前瞻性、多机构观察性研究。
Respir Investig. 2020 Jan;58(1):74-80. doi: 10.1016/j.resinv.2019.10.002. Epub 2019 Nov 11.